The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease

Multiple sclerosis is a demyelinating disease, characterized by inflammation in the brain and spinal cord, possibly due to autoimmunity. Large-scale sequencing of cDNA libraries, derived from plaques dissected from brains of patients with multiple sclerosis (MS), indicated an abundance of transcript...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) Jg. 294; H. 5547; S. 1731 - 1735
Hauptverfasser: Chabas, Dorothée, Baranzini, Sergio E., Mitchell, Dennis, Claude C. A. Bernard, Rittling, Susan R., Denhardt, David T., Sobel, Raymond A., Lock, Christopher, Karpuj, Marcela, Pedotti, Rosetta, Heller, Renu, Oksenberg, Jorge R., Steinman, Lawrence
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Washington, DC American Society for the Advancement of Science 23.11.2001
American Association for the Advancement of Science
The American Association for the Advancement of Science
Schlagworte:
ISSN:0036-8075, 1095-9203
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Multiple sclerosis is a demyelinating disease, characterized by inflammation in the brain and spinal cord, possibly due to autoimmunity. Large-scale sequencing of cDNA libraries, derived from plaques dissected from brains of patients with multiple sclerosis (MS), indicated an abundance of transcripts for osteopontin (OPN). Microarray analysis of spinal cords from rats paralyzed by experimental autoimmune encephalomyelitis (EAE), a model of MS, also revealed increased OPN transcripts. Osteopontin-deficient mice were resistant to progressive EAE and had frequent remissions, and myelin-reactive T cells in OPN-/-mice produced more interleukin 10 and less interferon-γ than in OPN+/+mice. Osteopontin thus appears to regulate T helper cell-1 (TH1)-mediated demyelinating disease, and it may offer a potential target in blocking development of progressive MS.
Bibliographie:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-2
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0036-8075
1095-9203
DOI:10.1126/science.1062960